Lobeglitazone

Description: Lobeglitazone, also known as CKD-501, is an antidiabetic drug in the thiazolidinedione class of drugs. As an agonist for both PPARalpha and PPARgamma, it works as an insulin sensitizer by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. Target: Others. Smiles: O(C=1C=C(N(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C)N=CN1)C4=CC=C(OC)C=C4